Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Inventory (2024 - 2025)

Historic Inventory for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to $7.1 million.

  • Day One Biopharmaceuticals' Inventory rose 15817.18% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 15817.18%. This contributed to the annual value of $3.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Inventory of $7.1 million as of Q3 2025, which was up 15817.18% from $6.5 million recorded in Q2 2025.
  • Day One Biopharmaceuticals' Inventory's 5-year high stood at $7.1 million during Q3 2025, with a 5-year trough of $151000.0 in Q2 2024.